TAPI (Teva Active Pharmaceutical Ingredients) - Active Pharmaceutical Ingredients

With more than 70 years of experience and over $1.9 billion in annual sales, TAPI (Teva Active Pharmaceutical Ingredients) is a leading global supplier of active pharmaceutical ingredients. TAPI is a stand-alone business unit of Teva Pharmaceutical Industries.

TAPI offers a rich portfolio of over 290 active pharmaceutical ingredients with superior customer service, customised solid-state specifications and unparalleled intellectual property (IP) assets that protect your freedom of operation. Our customers are leading generic pharmaceutical companies who have found TAPI to be a reliable and long-term supplier.

Research and development for API manufacture

The R&D group at TAPI boasts a dedicated team of over 600 top scientists located in seven development centres worldwide, specialising in the fields of chemical synthesis, fermentation, high potency, plant extract, synthetic peptides, vitamin D derivatives, prostaglandins, and analytical and solid-state research and development.

Our profound investment in research and development generates a steady flow of API products, enabling the timely introduction of pharmaceutical products to market. Owing to this cost-conscious market 40% of our R&D is dedicated to cost reduction through automation and efficiency, enabling our customers to remain competitive in the marketplace.

Top-quality active pharmaceutical ingredients

For over 70 years quality has been the cornerstone upon which TAPI is built, enabling us to consistently deliver top-quality products and services. Our commitment to quality is evidenced every day by our compliance with current GMP standards, as well as regular inspections by the FDA, other health authorities and customers.

Active pharmaceutical ingredients IP portfolio

For over a decade TAPI has been a leader in the API industry through the IP value proposition we offer to our customers. Our extensive IP portfolio - developed based on the innovations of the TAPI R&D group, and filed and prosecuted by our in-house patent group - numbers over 4,500 granted patents and pending applications worldwide. Building a strong intellectual property portfolio is a cornerstone of TAPI’s strategy and is one of our main differentiators in the marketplace.

Our stringent standards for freedom to operate opinions, coupled with over 20 years of global litigation experience, provide our customers with high confidence levels and decreased time to market.

Customised particle size distribution (PSD), bulk density and specific surface area

Our 21 manufacturing sites employ over 4,600 professionals worldwide. TAPI equips its production facilities with cutting-edge technologies and state-of-the art computerised systems to maintain its consistently high product quality, while continuously improving productivity and reliability.

Our advanced technology and our experts in the field of solid-state enable us to deliver customised particle size distribution (PSD), bulk density, specific surface area and more through process control and a variety of milling equipment. As part of an ongoing commitment to support our customers, TAPI continues to invest in building and expanding production capacities.

API manufacturing and customer service

The excellence of our customer service is yet another dimension of our commitment to quality. Our global dedicated and capable customer service team of over 30 customer service and 120 supply chain professionals provides full technical and scientific support at the highest level to our customers across the globe.